[144] TSS, Inc. SEC Filing
TSSI Form 144: The filing notifies proposed sale of 23,908 common shares by an insider, acquired on 06/27/2025 through restricted stock vesting under a registered plan. The securities are listed on NASDAQ with an approximate sale date of 08/28/2025 and an aggregate market value reported as $386,343.72. The filing shows 25,364,244 shares outstanding, indicating the proposed sale is a small fraction of total equity.
The filer also reported a prior sale on 08/27/2025 of 2,917 shares for gross proceeds of $47,338.24. The acquisition was recorded as payment for services rendered. The form includes the standard insider representation that no undisclosed material adverse information is known to the seller.
- Compliance: The insider filed a Rule 144 notice providing required details about acquisition, planned sale date, broker, and aggregate market value.
- Compensation context: Shares were acquired via restricted stock vesting under a registered plan, indicating the sale relates to compensation rather than an unexpected liquidity event.
- None.
Insights
TL;DR: Small insider sale from vested restricted stock; transaction size is immaterial relative to total shares outstanding.
The filing shows a proposed sale of 23,908 shares with an aggregate market value of $386,343.72 against 25,364,244 shares outstanding, representing roughly 0.094% of outstanding stock. The shares were acquired via restricted stock vesting and recorded as consideration for services rendered, which is a common non-cash compensation mechanism. A recent prior sale of 2,917 shares for $47,338.24 was also disclosed. For investors, this appears to be routine compensation-related selling rather than a material disposition that would typically trigger market concern.
TL;DR: Disclosure is timely and follows Rule 144 mechanics; no governance red flags evident from the filing alone.
The Form 144 provides the required particulars: acquisition date (06/27/2025), nature of acquisition (restricted stock vesting under a registered plan), and planned sale timing (approx. 08/28/2025). The seller attests to absence of undisclosed material adverse information. These elements satisfy standard disclosure and procedural expectations for insider transactions. Absent additional context such as concentrated selling or concurrent disclosures, this filing does not itself indicate governance concerns.